Chemicals and pharmaceuticals (U.S.)
Industry categories (first two SIC digits)
Companies in Chemicals and pharmaceuticals (56)
Tables scroll sideways
| Company | Ticker | Revenue | Operating margin | Industry (SIC) | Fiscal year end |
|---|---|---|---|---|---|
| Johnson & Johnson | JNJ | US$94.2 billion | — | Chemicals and pharmaceuticals | 2025-12-28 |
| Procter & Gamble | PG | US$87.0 billion | 22.7% | Chemicals and pharmaceuticals | 2026-06-30 |
| ELI Lilly AND | LLY | US$65.2 billion | — | Chemicals and pharmaceuticals | 2025-12-31 |
| Merck & Co | MRK | US$65.0 billion | — | Chemicals and pharmaceuticals | 2025-12-31 |
| Pfizer | PFE | US$62.6 billion | — | Chemicals and pharmaceuticals | 2025-12-31 |
| AbbVie | ABBV | US$61.2 billion | 24.6% | Chemicals and pharmaceuticals | 2025-12-31 |
| BRISTOL-MYERS Squibb | BMY | US$48.2 billion | — | Chemicals and pharmaceuticals | 2025-12-31 |
| Abbott Laboratories | ABT | US$44.3 billion | 18.2% | Chemicals and pharmaceuticals | 2025-12-31 |
| DOW | DOW | US$40.0 billion | — | Chemicals and pharmaceuticals | 2025-12-31 |
| Amgen | AMGN | US$36.8 billion | 24.7% | Chemicals and pharmaceuticals | 2025-12-31 |
| Lyondellbasell Industries N.V | LYB | US$30.2 billion | -1.4% | Chemicals and pharmaceuticals | 2025-12-31 |
| Gilead Sciences | GILD | US$29.4 billion | 34.0% | Chemicals and pharmaceuticals | 2025-12-31 |
| COLGATE-PALMOLIVE | CL | US$20.4 billion | 16.2% | Chemicals and pharmaceuticals | 2025-12-31 |
| Teva Pharmaceutical Industries Limited | TEVA | US$17.3 billion | 12.5% | Chemicals and pharmaceuticals | 2025-12-31 |
| Ecolab | ECL | US$16.1 billion | 17.0% | Chemicals and pharmaceuticals | 2025-12-31 |
| PPG Industries | PPG | US$15.9 billion | — | Chemicals and pharmaceuticals | 2025-12-31 |
| Kenvue | KVUE | US$15.1 billion | 16.0% | Chemicals and pharmaceuticals | 2025-12-28 |
| THE Estee Lauder Companies | EL | US$15.0 billion | 5.2% | Chemicals and pharmaceuticals | 2026-06-30 |
| Regeneron Pharmaceuticals | REGN | US$14.3 billion | 24.9% | Chemicals and pharmaceuticals | 2025-12-31 |
| Viatris | VTRS | US$14.3 billion | -18.6% | Chemicals and pharmaceuticals | 2025-12-31 |
| Mosaic | MOS | US$12.1 billion | 6.8% | Chemicals and pharmaceuticals | 2025-12-31 |
| AIR Products AND Chemicals | APD | US$12.0 billion | -7.3% | Chemicals and pharmaceuticals | 2025-09-30 |
| Vertex Pharmaceuticals INC / MA | VRTX | US$12.0 billion | 34.8% | Chemicals and pharmaceuticals | 2025-12-31 |
| Westlake | WLK | US$11.2 billion | -14.1% | Chemicals and pharmaceuticals | 2025-12-31 |
| International Flavors & Fragrances | IFF | US$10.9 billion | -3.5% | Chemicals and pharmaceuticals | 2025-12-31 |
| Biogen | BIIB | US$9.9 billion | — | Chemicals and pharmaceuticals | 2025-12-31 |
| Celanese | CE | US$9.5 billion | -8.2% | Chemicals and pharmaceuticals | 2025-12-31 |
| Zoetis | ZTS | US$9.5 billion | — | Chemicals and pharmaceuticals | 2025-12-31 |
| Eastman Chemical | EMN | US$8.8 billion | — | Chemicals and pharmaceuticals | 2025-12-31 |
| RPM International | RPM | US$7.9 billion | — | Chemicals and pharmaceuticals | 2026-05-31 |
| The Clorox | CLX | US$7.1 billion | — | Chemicals and pharmaceuticals | 2025-06-30 |
| CF Industries Holdings | CF | US$7.1 billion | 32.5% | Chemicals and pharmaceuticals | 2025-12-31 |
| Dupont DE Nemours | DD | US$6.8 billion | — | Chemicals and pharmaceuticals | 2025-12-31 |
| Olin | OLN | US$6.8 billion | 0.1% | Chemicals and pharmaceuticals | 2025-12-31 |
| Organon | OGN | US$6.2 billion | — | Chemicals and pharmaceuticals | 2025-12-31 |
| Church & Dwight CO | CHD | US$6.2 billion | 17.4% | Chemicals and pharmaceuticals | 2025-12-31 |
| The Chemours | CC | US$5.8 billion | — | Chemicals and pharmaceuticals | 2025-12-31 |
| Coty | COTY | US$5.8 billion | -1.4% | Chemicals and pharmaceuticals | 2026-06-30 |
| Huntsman | HUN | US$5.7 billion | -2.3% | Chemicals and pharmaceuticals | 2025-12-31 |
| Sealed AIR | — | US$5.4 billion | 13.5% | Chemicals and pharmaceuticals | 2025-12-31 |
| Beone Medicines | ONC | US$5.3 billion | 8.4% | Chemicals and pharmaceuticals | 2025-12-31 |
| Albemarle | ALB | US$5.1 billion | -7.1% | Chemicals and pharmaceuticals | 2025-12-31 |
| Axalta Coating Systems | AXTA | US$5.1 billion | 14.4% | Chemicals and pharmaceuticals | 2025-12-31 |
| Elanco Animal Health | ELAN | US$4.7 billion | — | Chemicals and pharmaceuticals | 2025-12-31 |
| Idexx Laboratories | IDXX | US$4.3 billion | 31.6% | Chemicals and pharmaceuticals | 2025-12-31 |
| Jazz Pharmaceuticals | JAZZ | US$4.3 billion | -10.1% | Chemicals and pharmaceuticals | 2025-12-31 |
| Union Carbide | — | US$4.0 billion | — | Chemicals and pharmaceuticals | 2025-12-31 |
| Solstice Advanced Materials | SOLS | US$3.9 billion | — | Chemicals and pharmaceuticals | 2025-12-31 |
| Alnylam Pharmaceuticals | ALNY | US$3.7 billion | 13.5% | Chemicals and pharmaceuticals | 2025-12-31 |
| Cabot | CBT | US$3.7 billion | 16.7% | Chemicals and pharmaceuticals | 2025-09-30 |
| Fuller H B | FUL | US$3.5 billion | — | Chemicals and pharmaceuticals | 2025-11-29 |
| FMC | FMC | US$3.5 billion | -47.0% | Chemicals and pharmaceuticals | 2025-12-31 |
| Scotts Miracle-Gro | SMG | US$3.4 billion | 10.5% | Chemicals and pharmaceuticals | 2025-09-30 |
| Avient | AVNT | US$3.3 billion | 6.2% | Chemicals and pharmaceuticals | 2025-12-31 |
| Biomarin Pharmaceutical | BMRN | US$3.2 billion | 12.7% | Chemicals and pharmaceuticals | 2025-12-31 |
| United Therapeutics | UTHR | US$3.2 billion | 46.9% | Chemicals and pharmaceuticals | 2025-12-31 |